However, MTAP-loss CRC was also associated with a higher frequency of alterations in STK11 and KEAP1, which have been linked to immunotherapy resistance in NSCLC and pan-cancer cohorts.44,45. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.